Now I have a thorough understanding of the paper and can verify the reviews against the actual content. Let me construct the consolidated review.

## Summary

This paper proposes LeFusion, a lesion-focused diffusion model for controllable pathology synthesis. The key ideas are: (1) redesigning the diffusion loss to operate only within lesion masks, avoiding the need to generate complex backgrounds; (2) integrating forward-diffused real backgrounds into the reverse diffusion process to guarantee background preservation; (3) histogram-based texture control for multi-peak lesions; (4) multi-channel decomposition for multi-class lesions; and (5) DiffMask for controllable, diverse lesion mask generation. The method is validated on LIDC lung nodule CT and Emidec cardiac MRI datasets, showing that synthetic data from LeFusion improves downstream segmentation performance of nnUNet and SwinUNETR.

## Strengths

1. **Principled lesion-focused training objective**: Redesigning the diffusion loss to apply only within the lesion mask (Eq. 4) is a well-motivated departure from standard inpainting. By focusing model capacity on lesion generation and using forward-diffused backgrounds during inference, the approach avoids wasting parameters on background reconstruction—a genuine practical advantage in data-limited medical settings. The downstream improvements (+5.18% Dice for nnUNet, +4.75% for SwinUNETR over baselines without synthetic data) demonstrate that this design choice translates to real utility.

2. **Background preservation via forward-diffused background integration**: The method of combining forward-diffused real backgrounds with reverse-diffused foregrounds during inference (Eq. 3) theoretically guarantees background integrity, directly addressing a known limitation of conditional diffusion methods that must reconstruct both lesion and background. This is a clean solution to a well-recognized problem in medical image synthesis.

3. **Histogram-based texture control for multi-peak lesions**: Using lesion texture histograms as a cross-attention condition is a simple yet effective solution to the multi-peak mode collapse problem in lesions like lung nodules (ground-glass, part-solid, solid). The paper empirically demonstrates (Sec. 4.3, Fig. 6) that without this control, the model produces overly subtle, low-diversity lesions biased toward healthy appearance—making this contribution both necessary and well-validated for its target scenario.

4. **Multi-channel decomposition for multi-class lesions**: The strategy of generating each lesion class in a separate channel and combining them (Eq. 6) captures correlations between lesion types (MI and PMO in cardiac MRI). The ablation in Table 2 shows that joint modeling (LeFusion-J) outperforms separate modeling, providing clear evidence of this design's value for multi-class scenarios.

5. **Downstream task validation is appropriate and practical**: Rather than relying solely on perceptual metrics (which the paper correctly notes have limited correlation with medical image quality), the evaluation focuses on downstream segmentation performance using two state-of-the-art architectures across two different modalities and tasks. This is the right evaluation paradigm for a data augmentation method.

## Weaknesses

### Fatal
None.

### Major

1. **No statistical significance reporting**: Tables 1 and 2 report single-point Dice/NSD values without standard deviations, confidence intervals, or variance across runs/folds. Given the modest test set sizes (10 cardiac cases, 520 lung nodule ROIs), the reported differences—especially small ones like LeFusion-H vs. Copy-Paste on LIDC (a ~0.2 point difference)—cannot be assessed for significance. Without this information, strong claims like "significantly improves performance" (abstract) are not fully supported. This is the most consequential weakness because it affects interpretation of all experimental results.

2. **Incomplete isolation of the lesion-focused loss contribution**: The comparison against RePaint is meant to show the benefit of the lesion-focused loss, but this comparison is confounded. The paper describes RePaint as using "standard image diffusion models during training" without specifying whether the model was trained on the same medical data with the same architecture (just with global loss) or uses a pretrained model from a different domain. A clean ablation—same framework, same training data, same architecture, differing only in lesion-focused vs. global loss—is missing and would substantiate the paper's central methodological claim.

3. **Histogram-based control lacks implementation detail**: The paper states that "the lesion texture histogram h is used as a condition via cross attention" (Sec. 3.2) but does not specify how the histogram is featurized (number of bins, intensity range, whether normalized), how it is integrated into the U-Net architecture, or how inference-time histogram adjustment works. These details are necessary for reproducibility and for understanding the method's practical behavior.

4. **Copy-Paste baseline is competitive in several settings**: On LIDC with nnUNet (Table 1), Copy-Paste (a simple heuristic that copies real lesion textures) achieves results comparable to or better than LeFusion in some data conditions. The paper's claim of consistent superiority over existing methods is weakened by this observation. While LeFusion excels in other settings (e.g., SwinUNETR, multi-class lesions), the paper should acknowledge and discuss this more honestly.

### Minor

1. **Limited quantitative analysis of synthetic image diversity**: The histogram control analysis (Sec. 4.3, Fig. 6) provides qualitative evidence and a simple PSNR/SSIM diversity comparison, but does not quantify how well the generated lesion histograms match the target histograms (e.g., KL divergence). Similarly, DiffMask quality is only assessed qualitatively (Fig. A1–A2 referenced), without quantitative mask similarity metrics (e.g., Dice with real masks).

2. **Potential positional bias in normal ROI extraction**: The paper extracts 3,076 normal ROIs from healthy patients "representing regions where lung nodules typically appear" but does not specify how these regions are determined. If this relies on heuristic or manual selection, it could introduce positional bias that affects the generalizability of results.

3. **No synthetic-only training evaluation**: While the paper evaluates combinations of real and synthetic data, it does not report results from training segmentation models exclusively on synthetic data. This would reveal whether LeFusion's synthetic images are realistic enough to learn from independently, and would strengthen the claim about synthetic data quality.

4. **Limited discussion of failure modes**: The visual quality assessment shows selected successful cases. The paper would benefit from discussing failure cases—e.g., boundary artifacts, unrealistic textures, or cases where the generated lesion does not blend well with the background.

### Trivial
None significant.

## Nice-to-Haves

- Comparison with standard data augmentation (rotations, elastic deformations, intensity shifts) applied to real pathological data would contextualize the benefit of synthetic data over conventional augmentation.
- Comparison with a diffusion model trained end-to-end on full pathological volumes (rather than inpainting) would further isolate the benefit of the background-preserving approach.
- Quantitative analysis of mask quality (e.g., Dice/Hausdorff distance between DiffMask outputs and real masks) would strengthen the DiffMask contribution.
- Analysis of synthetic data coverage across rare lesion subtypes would address safety/fairness concerns.

## Removed Points

These points are flagged to be removed, treat them with caution:
- The criticism about "missing concurrent work (Lai et al., 2024; Wu et al., 2024; Zhu et al., 2024)" being unavailable: The paper explicitly notes code unavailability; this is a practical constraint, not an author error. However, the broader point about missing established baselines (Med-DDPM, VQGAN+Latent Diffusion, etc.) is retained as a minor weakness.
- The criticism that "the paper dismisses comparisons with concurrent work": The paper acknowledges the limitation honestly. The instruction about removing criticisms that question existence of cited works applies here—the paper's cited work exists; the reviewer's complaint is about missing comparisons, which is kept as a minor weakness above.
- The suggestion that perceptual metrics (FID/KID) are necessary: The paper provides a reasoned justification (limited correlation with medical image quality, Sec. 4.3) for focusing on downstream evaluation. This is a defensible methodological choice, not a flaw. The point is moved here but the downstream-only approach remains a limitation for cross-paper comparison.
- The criticism about "no evaluation of safety/fairness for underrepresented lesion types": This asks for analysis beyond the paper's stated scope. The ethics statement appropriately acknowledges fraud risk but fairness analysis of synthetic data distributions is not standard in this type of contribution.

## Novel Insights

The interaction between the two reviews surfaces a tension that the paper itself does not fully address: the lesion-focused loss makes the training task easier (only predict noise within the mask), but the paper attributes the resulting performance gains to "focusing on lesion information" rather than acknowledging that it is also simply a simpler learning problem. The comparison with RePaint would resolve this if it were controlled for architecture and training data, but as designed, it leaves open the question of how much of LeFusion's improvement comes from the loss design vs. other factors (e.g., training a model from scratch on the specific medical data vs. using a pretrained model). Separately, the paper's core strength—its practical, engineering-oriented approach to lesion synthesis—is somewhat undermined by the lack of error bars, which is a basic expectation for empirical work in medical imaging. The combination of these two factors (ablation gap + missing error bars) means the paper's headline claims are plausible but not yet rigorously proven.

## Suggestions

1. **Report error bars**: Repeat experiments with multiple random seeds (at least 3–5) and report mean ± std for all Dice/NSD values in Tables 1 and 2. This is the single most impactful improvement for establishing the reliability of the results.

2. **Add a clean ablation of the lesion-focused loss**: Train a variant of LeFusion with global noise-prediction loss (standard diffusion training) but using the same architecture, training data, and inference-time inpainting scheme. Compare directly with the lesion-focused loss variant to isolate the contribution.

3. **Provide histogram implementation details**: Specify the histogram binning strategy, intensity range, featurization method, and cross-attention integration mechanism for reproducibility.

4. **Add quantitative mask evaluation**: Report Dice or other overlap metrics between DiffMask outputs and real masks, and compare with hand-crafted mask quality.

5. **Tone down claims where evidence is mixed**: Acknowledge that Copy-Paste is a competitive baseline for single-class lung nodule synthesis and clarify that LeFusion's advantages are most pronounced for multi-class lesions and when histogram control is needed.

## Score and Decision

This paper introduces a well-motivated framework for controllable lesion synthesis with several sensible technical contributions (lesion-focused loss, background preservation, histogram control for multi-peak lesions, multi-channel decomposition for multi-class lesions, and DiffMask). The problem framing is clear and the downstream evaluation paradigm is appropriate. However, the experimental validation has meaningful gaps—most critically, the absence of error bars and the incomplete isolation of the lesion-focused loss via clean ablation. The competitiveness of Copy-Paste in some settings further tempers the claimed improvements. These issues are addressable but make the current evidence base insufficient to fully support the paper's strongest claims.

The paper should be revised to address these concerns, particularly the missing error bars and ablations. With these additions, it would be a solid contribution to the medical image synthesis literature.

MY FINAL SCORE: <pineapple>5.5</pineapple>
MY FINAL DECISION: <orange>Accept</orange>